Vitadao - Свежие новости [ Фото в новостях ] | |
New Frontiers in Cancer and Longevity Research: VitaDAO’s DeSci Initiative
VitaDAO initiates Matrix Biosciences, focusing on aging and cancer. Backed by a community vote and Dr. Vera Gorbunova, it sets the stage for preclinical work. The post New Frontiers in Cancer and Longevity Research: VitaDAO’s DeSci Initiative appeared first on NFT News Today. дальше »
2023-10-19 18:50 | |
|
VitaDAO - Pfizer Ventures raise millions for research on extending human life
VitaDAO has raised $4.1 million from Pfizer Ventures among other investors. The latest fund raiser will fund longevity research projects and the development of its first biotech startup. VitThe post VitaDAO - Pfizer Ventures raise millions for research on extending human life appeared first on AMBCrypto. дальше »
2023-1-31 14:30 | |
|
|
Decentralized project VitaDAO raises $4.1m from Pfizer, others
VitaDAO has secured $4.1 million in a token-based funding round led by Pfizer Ventures, with participation from Balaji Srinivasan, L1 Digital, and several others дальше »
2023-1-30 21:57 | |
|
|
Molecule Partners With VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result... дальше »
2021-8-19 08:07 | |
|
|
Molecule Partners VitaDAO, Nevermined for Biopharma Research
Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. The post Molecule Partners VitaDAO, Nevermined for Biopharma Research appeared first on BeInCrypto. дальше »
2021-8-19 16:23 | |
|
|
Molecule Partners with VitaDAO and Nevermined Creating First-Ever Biopharma IP-to-NFT Transfer for Longevity Research
Press Release: Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. дальше »
2021-8-18 16:00 | |
|
|
Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovationRead More дальше »
2021-8-18 16:00 | |
|
|
Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
Press Release: Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. дальше »
2021-8-18 16:00 | |
|
|
Molecule, VitaDAO & Nevermined partner to create Biopharma IP-to-NFT transfer
Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfuThe post Molecule, VitaDAO & Nevermined partner to create Biopharma IP-to-NFT transfer appeared first on AMBCrypto. дальше »
2021-8-18 16:00 | |
|
|